Skip to main content

Heterogeneity of Treatment Effects Among Patients With Type 2 Diabetes and Elevated Body Mass Index in a Study Comparing Group Medical Visits Focused on Weight Management and Medication Intensification.

Publication ,  Journal Article
Kobe, EA; Crowley, MJ; Jeffreys, AS; Yancy, WS; Zervakis, J; Edelman, D; Voils, CI; Maciejewski, ML; Coffman, CJ
Published in: Med Care
November 1, 2021

BACKGROUND: Illuminating heterogeneity of treatment effect (HTE) within trials is important for identifying target populations for implementation. OBJECTIVE: The aim of this study was to examine HTE in a trial of group medical visits (GMVs) for patients with type 2 diabetes and elevated body mass index. RESEARCH DESIGN AND MEASURES: Participants (n=263) were randomized to GMV-based medication management plus low carbohydrate diet-focused weight management (WM/GMV; n=127) or GMV-based medication management alone (GMV; n=136) for diabetes control. We used QUalitative INteraction Trees, a tree-based clustering method, to identify subgroups with greater improvement in hemoglobin A1c (HbA1c) and weight from either WM/GMV or GMV. Subgroup predictors included 32 baseline demographic, clinical, and psychosocial factors. Internal validation was conducted to estimate bias in the range of mean outcome differences between arms. RESULTS: QUalitative INteraction Trees analyses indicated that for patients who had not previously attempted weight loss, WM/GMV resulted in better glycemic control than GMV (mean difference in HbA1c improvement=1.48%). For patients who had previously attempted weight loss and had lower cholesterol and blood urea nitrogen, GMV was better than WM/GMV (mean difference in HbA1c improvement=1.51%). No treatment-subgroup effects were identified for weight. Internal validation resulted in moderate corrections in mean HbA1c differences between arms; however, differences remained in the clinically significant range. CONCLUSION: This work represents a novel step toward targeting care approaches for patients to maximize benefit based on individual patient characteristics.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Med Care

DOI

EISSN

1537-1948

Publication Date

November 1, 2021

Volume

59

Issue

11

Start / End Page

1031 / 1038

Location

United States

Related Subject Headings

  • Weight Loss
  • Office Visits
  • Hypoglycemic Agents
  • Humans
  • Health Policy & Services
  • Group Processes
  • Diabetes Mellitus, Type 2
  • Body Mass Index
  • 4407 Policy and administration
  • 4203 Health services and systems
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kobe, E. A., Crowley, M. J., Jeffreys, A. S., Yancy, W. S., Zervakis, J., Edelman, D., … Coffman, C. J. (2021). Heterogeneity of Treatment Effects Among Patients With Type 2 Diabetes and Elevated Body Mass Index in a Study Comparing Group Medical Visits Focused on Weight Management and Medication Intensification. Med Care, 59(11), 1031–1038. https://doi.org/10.1097/MLR.0000000000001642
Kobe, Elizabeth A., Matthew J. Crowley, Amy S. Jeffreys, William S. Yancy, Jennifer Zervakis, David Edelman, Corrine I. Voils, Matthew L. Maciejewski, and Cynthia J. Coffman. “Heterogeneity of Treatment Effects Among Patients With Type 2 Diabetes and Elevated Body Mass Index in a Study Comparing Group Medical Visits Focused on Weight Management and Medication Intensification.Med Care 59, no. 11 (November 1, 2021): 1031–38. https://doi.org/10.1097/MLR.0000000000001642.
Kobe EA, Crowley MJ, Jeffreys AS, Yancy WS, Zervakis J, Edelman D, Voils CI, Maciejewski ML, Coffman CJ. Heterogeneity of Treatment Effects Among Patients With Type 2 Diabetes and Elevated Body Mass Index in a Study Comparing Group Medical Visits Focused on Weight Management and Medication Intensification. Med Care. 2021 Nov 1;59(11):1031–1038.

Published In

Med Care

DOI

EISSN

1537-1948

Publication Date

November 1, 2021

Volume

59

Issue

11

Start / End Page

1031 / 1038

Location

United States

Related Subject Headings

  • Weight Loss
  • Office Visits
  • Hypoglycemic Agents
  • Humans
  • Health Policy & Services
  • Group Processes
  • Diabetes Mellitus, Type 2
  • Body Mass Index
  • 4407 Policy and administration
  • 4203 Health services and systems